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56 Uptake rates of antenatal vaccination remain suboptimal. Our aims were to determine: (1) 
57 the acceptability of routine vaccination among pregnant women, (2) the confidence of 
58 maternity healthcare professionals (HCPs) discussing vaccination and (3) HCP opinion 
59 regarding the optimum healthcare site for vaccine administration.
60
61 Methods
62 Separate questionnaires for pregnant women and HCPs were distributed within four NHS 
63 trusts in South England (July 2017-January 2018). 
64
65 Results
66 Responses from 314 pregnant women and 204 HCPs (18% obstetricians, 75% midwives, 
67 7% unidentified) were analysed. Previous/intended uptake of influenza and pertussis 
68 vaccination was 78% and 92%, respectively. The commonest reason for declining 
69 vaccination was feared side-effects for their child. White British women (79%) were 
70 significantly more accepting of influenza (85% vs. 61%, OR 3.25, 95% CI: 1.67-6.32) and 
71 pertussis vaccination (96% vs. 83%, OR 4.83, 95% CI: 1.77-13.19) compared with non-
72 white-British women. Among HCPs, 25% were slightly or not-at-all confident discussing 
73 vaccination. Obstetricians felt significantly more confident discussing pertussis vaccination 
74 than midwives (68% vs. 55% were very/moderately confident, OR 2.05, 95% CI: 1.02-4.12). 
75 Among HCPs, 53%, 25% and 16% thought vaccines should be administered in primary 
76 care (general practice), community midwifery and in hospital, respectively. 
77
78 Conclusion
79 Misconceptions exist regarding safety/efficacy of antenatal vaccination, and framing 
80 information towards the child’s safety may increase uptake. Education of HCPs is essential, 
81 and vaccine promotion should be incorporated into routine antenatal care, with an 
82 emphasis on women from ethnic minorities. Administration of vaccines in primary care 





89 Both influenza and pertussis result in severe outcomes for pregnant women and their 
90 infants (including respiratory illness and death) 1  2, and vaccination in pregnancy is an 
91 effective means of protection until the period of greatest susceptibility has passed  3–6. In 
92 the UK, influenza and pertussis vaccination have been routinely recommended for use in 
93 pregnancy since 2010 and 2012, respectively  7. 
94
95 Unfortunately, achieving vaccine acceptance among pregnant women and healthcare 
96 professionals (HCPs) remains a global challenge  8. The World Health Organization (WHO) 
97 Strategic Advisory Group of Experts on Immunization have called for improved monitoring 
98 of vaccine acceptance, and research into the socio-economic determinants of attitudes 
99 towards vaccines  9. The uptake of influenza and pertussis vaccination during pregnancy in 
100 England over the September 2016 - January 2017 period was 44.9% and 74.2%, 
101 respectively  10  11. Pertussis vaccination uptake in the UK has gradually climbed from 
102 around 50% since its introduction in 2012, yet influenza vaccine uptake has been relatively 
103 static, and remains well below the WHO target of 75%  10. Furthermore, coverage varies 
104 significantly between different regions of the UK, with average uptake approximately 10% 
105 and 20% lower in London than in northern England for influenza and pertussis, respectively 
106 9  11. 
107
108 Uptake of vaccination could be significantly improved if we are able to fully understand the 
109 decision-making processes to acceptance. Furthermore, it is well-acknowledged that 
110 encouragement from a familiar HCP significantly improves vaccine acceptance 12  13, yet 
111 few studies have considered the extent to which HCPs feel confident discussing 
112 vaccinations with pregnant women, and the associated factors which might influence this. 
113 Optimizing the healthcare site of vaccine administration is also an important issue that may 
114 have a considerable impact on vaccine uptake, yet few studies have considered the support 
115 of HCPs for alternative approaches. In the UK, vaccination is free-of-charge, and is usually 
116 provided within primary care (general practice), and is less commonly available within 
117 secondary (hospital-based) care. This may present a logistical barrier if it requires women 
118 to arrange extra appointments, and more convenient approach might be to routinely 
119 administer vaccination at the time of antenatal appointments.
120
121 Ours aims were therefore: (1) to identify factors associated with the acceptance of influenza 
122 and pertussis vaccinations in pregnancy, (2) to establish the level of confidence among 
123 HCPs in discussing vaccination with pregnant women, as well as the factors which might 







132 Questionnaire design and development
133 Two separate anonymized questionnaires were developed for pregnant women and 
134 maternity HCPs. These were developed with input from a multi-disciplinary study team 
135 including obstetricians, pediatricians, health psychologists, and clinical academic trainees. 
136 The questionnaires consisted of closed questions and a single free-text box in which 
137 participants could add further comments. 
138
139 The questions analyzed here (see supplementary file) were nested within a larger 
140 questionnaire focussing on the attitudes of pregnant women and HCPs to both routine 
141 vaccination in pregnancy and to clinical trials of vaccines in pregnancy. The current paper 
142 focuses only on the questions relating to routinely recommended vaccines. Pregnant 
143 women were asked whether 1) they had/planned to receive influenza and pertussis 
144 vaccination and 2) the motivating reasons for accepting or declining these vaccines. 
145 Maternity HCPs were asked whether 1) they felt confident providing advice regarding these 
146 two vaccines and 2) their opinion regarding the optimal healthcare site of vaccine 
147 administration. Ethical approval was granted (reference 17/LO/0537) and the study was 
148 registered on ClinicalTrials.gov prior to recruitment (NCT03096574).
149
150 Study population and recruitment
151 The questionnaire for pregnant women was administered to women (aged > 16 years at the 
152 time of completing the questionnaire) attending for routine antenatal care at four study sites 
153 in southern England: University Hospital Southampton NHS Foundation Trust, University 
154 Hospitals Bristol NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, 
155 and St George’s University Hospitals NHS Foundation Trust, London. These sites were 
156 selected because of their high birth rates (all > 4000 births/year)  14, and by distributing our 
157 questionnaire across four hospitals, we attempted to increase the demographic diversity of 
158 our study population.
159
160 The HCP questionnaire was administered to those working in either midwifery or obstetrics 
161 at the same four study sites. It should be noted that routine antenatal care in the UK is 
162 usually midwife-led (unless a pregnancy is deemed high-risk), and therefore the majority of 
163 potential respondents to our questionnaire were midwives, rather than obstetricians. 
164 Recruitment of participants took place from July 2017 to January 2018. Pregnant women 
165 were recruited in person via opportunistic sampling at antenatal clinics or wards, and given 
166 paper questionnaires to complete. Maternity HCPs were either recruited via email 
167 (containing a link to an online questionnaire) or face-to-face by opportunistic sampling, in 
168 which case they were also given paper questionnaires. The initial response rate from HCPs 
169 was promoted by up to two further email reminders. Participation was voluntary and no 
170 financial or other incentive was offered. All participants gave informed consent. 
171
172 Questionnaire data analysis
173 Questionnaire data was entered at the lead site (Southampton) into iSurvey 
174 (www.isurvey.soton.ac.uk). Statistical analysis was performed using IBM SPSS Version 25. 
175 Logistic and ordinal regression analyses were performed for pregnant women and HCP 
176 responses, respectively, and adjusted odds ratios (ORs) were calculated. P-values <0.05 
177 were considered as statistically significant. Multicollinearity was examined using the 
178 tolerance test and the Variance Inflation Factor (VIF) to ensure variables with a VIF value 
179 exceeding 2.5 were not entered into the multivariate regression analysis.
5181 Results
182
183 A total of 525 participants completed the questionnaires: 321 pregnant women and 204 
184 HCPs (18% obstetricians, 75% midwives, and 7% unidentified). The numbers of 
185 respondents were relatively equally distributed between the four study sites. Eight 
186 questionnaires from pregnant women, and five from HCPs, were excluded due to largely 
187 incomplete or illegible responses, therefore 513 questionnaires (98%) were included in the 
188 analysis. The full characteristics of respondents, including demographic details, are 
189 displayed in Table 1. 
190
191 Responses from pregnant women
192 Regarding influenza vaccination: of 310 responses, 38% had been vaccinated, 40% were 
193 intending to be vaccinated, and 22% were not intending to be vaccinated. Regarding 
194 pertussis vaccination: of 302 responses, 56% had been vaccinated, 36% were intending to 
195 be vaccinated, and 8% were not intending to be vaccinated. The reasons for declining 
196 vaccination are displayed in Figure 1. A similar trend in responses was observed for both 
197 vaccines. The most commonly cited reason for declining was concern about possible side 
198 effects for their child. 
199
200 Binary logistic regression analysis (Table 2, supplementary information) demonstrated that 
201 women identifying themselves as White British (79% of respondents) were significantly 
202 more likely to accept influenza (85% vs. 61%, OR 3.25, 95% confidence interval [CI] 1.67-
203 6.32) and pertussis (96% vs. 83%, OR 4.83, 95% CI 1.77-13.19) vaccination compared to 
204 those identifying in all other ethnic groups. In the case of influenza vaccination, study site 
205 also had a significant effect, and participants at site B were significantly more likely to 
206 accept influenza vaccination than those at site D (91% vs. 64%, OR 4.20, 95% CI 1.47-
207 11.95). Participants’ age and whether they had previous children had no significant effect 
208 on vaccine uptake. In the qualitative analysis of the free text comments, pregnant women 
209 identified further concerns regarding vaccination in pregnancy, including damage to their 
210 unborn baby, vaccination being offered too late and insufficient information provided (see 
211 supplementary information).
212
213 Responses from maternity healthcare professionals
214 Out of 199 HCPs who responded, they were: extremely (25%), moderately (34%), 
215 somewhat (17%), slightly (16%) and not at all (8%) confident providing advice regarding 
216 influenza vaccination. For pertussis vaccination, they were: extremely (25%), moderately 
217 (32%), somewhat (16%), slightly (15%) and not at all confident (12%). See Figure 2.
218
219 Ordinal regression analysis (Table 3, supplementary information) demonstrated that 
220 obstetricians were significantly more likely than midwives to feel confident giving advice 
221 about the pertussis vaccine (68% vs. 55% were very/moderately confident, OR 2.05, 95% 
222 CI 1.02-4.12), however there was no significant difference between either profession for the 
223 influenza vaccine. On the other hand, longer experience in maternity care was associated 
224 with greater confidence giving advice regarding influenza vaccination, but not pertussis 
225 vaccination. Study site was also significantly associated with confidence providing advice 
226 for both vaccines, with HCPs from sites B and C being significantly more likely to feel 
227 confident than those in site D. Finally, health professional’s age and whether or not they 
228 had children of their own were not associated with greater confidence in discussing 
229 vaccination. No free-text comments from staff relating to influenza/pertussis vaccination 
230 were provided for analysis.
6231
232 With regards to the optimal healthcare site for vaccine administration during pregnancy 
233 (Figure 3), approximately one-half (53%) of HCP respondents thought that vaccines should 
234 be delivered in the primary care setting as part of general practice, 25% thought vaccines 
235 should be delivered in by midwives in the community, and 16% thought vaccines should be 
236 delivered in secondary care (at the time of antenatal appointments). The remaining 8% 
237 either thought that vaccination should be administered in both general practice and 











250 Vaccination in pregnancy remains a national and international priority for improving 
251 healthcare outcomes. Understanding women's and HCP’s opinions and attitudes to vaccine 
252 acceptance are important in explaining current vaccination attainment levels. Our aims 
253 were to identify factors associated with vaccine acceptance and hesitancy among pregnant 
254 women, to establish whether HCPs feel confident discussing vaccination with these women, 
255 and to establish where HCPs thought these vaccines should be administered.
256
257 Uptake of vaccination among pregnant women
258 Encouragingly, the acceptance of influenza and pertussis vaccination was high among 
259 pregnant women in this study. The most common reasons for vaccine hesitancy were 
260 concerns about side effects, and doubts regarding the effectiveness and need for 
261 vaccination. Perception of possible harm is commonly cited as the primary reason for 
262 vaccine refusal among previous studies  12  15, and women are usually more concerned 
263 about potential risks to their child’s health than their own 16. Clearly, important 
264 misconceptions still exist regarding the safety of vaccines, including the presence of ‘toxins’ 
265 such as thimerosal (a mercury-containing preservative removed from childhood vaccines in 
266 2001) that was proposed in 2005 to be associated with neurologic conditions, including 
267 autism 17. We recommend that vaccine advocacy should emphasise the safety and efficacy 
268 of vaccination, specifically towards protection of the baby. Furthermore, accessible 
269 alternatives to face-to-face counseling that been successfully used in the past have 
270 included social media and webcasts  18  19, mobile phone text messages (such as 
271 Text4baby) 20  21 and smart phone apps (such as MatImms 22).
272
273 Another important finding was that pregnant women of ethnic minorities were significantly 
274 less likely to accept vaccination than those identifying as ‘White British’. Previous research 
275 has similarly demonstrated lower vaccine acceptance among these groups  23–25, and these 
276 findings highlight the importance of taking into account possible cultural/religious and 
277 language barriers when counselling these women and producing educational materials. The 
278 underlying reasons for the difference in vaccine attitudes between ethnic groups remains a 
279 significant gap in our knowledge, and future studies in this specific area are needed. 
280 Interestingly, we did not find any significant effect of age or having children already in our 
281 study, however younger age has been shown to be associated with lower uptake in some 
282 previous studies  23  26. Study site had no effect on pertussis vaccine acceptance however 
283 there was significantly higher influenza vaccine acceptance among pregnant women at site 
284 B.  These results may be skewed by the recruitment season of this site, however, as 
285 recruitment here was all undertaken entirely during the influenza vaccination season (which 
286 runs from September to February).
287
288 Confidence of healthcare professionals and optimal healthcare site for vaccine 
289 administration
290 Very few previous studies  27 have investigated to what extent HCPs feel confident 
291 discussing vaccination with pregnant women. This is despite the fact that pregnant women 
292 consider their HCP their most trusted source of information, and encouragement from them 
293 has been shown to increase intention to receive vaccination by up to 20 times  13  12. 
294 Conversely, a lack of knowledge of the indications and benefits of vaccination among HCPs 
295 has been identified as a barrier to implementation of vaccination recommendations  28. 
296 Among HCPs in our study, a significant proportion were not confident providing advice to 
8297 pregnant women. Confidence also varied significantly by study site, suggesting that there is 
298 a potential risk of health inequalities based on differing levels of vaccine confidence and 
299 recommendations across the South of England. Further education of multidisciplinary HCPs 
300 is essential, and individual barriers to active promotion of these vaccines need to be 
301 identified and reduced. Individual sites should aim to establish areas of low confidence 
302 within their own working body and push to incorporate active promotion of vaccination into 
303 routine antenatal care. Also, while it should be noted that obstetricians, and those with more 
304 experience in maternity care, felt more confident giving advice about the pertussis and 
305 influenza vaccines, respectively, we suggest that education should not be aimed solely at a 
306 particular profession, or those new to maternity care. 
307
308 Finally, optimizing the healthcare site for vaccine administration is an important and topical 
309 issue which may have a considerable impact on vaccine uptake. In the UK, vaccination in 
310 pregnancy is usually provided in the primary care setting (within general practice), yet this 
311 presents a logistical barrier as it normally requires women to arrange extra primary care 
312 appointments. A more convenient and efficient approach might be to routinely offer and 
313 administer vaccination at the time of hospital antenatal appointments (such as the fetal 
314 anomaly scan at around 20 week’s gestation), either by incorporating vaccination directly 
315 into these clinics, or providing adjacent vaccination clinics, which women are invited to visit 
316 immediately before or after their regular antenatal appointment  29–31. Previous studies have 
317 demonstrated that vaccinating in secondary care may indeed improve uptake  29–31, yet 
318 support for this approach appeared to be low (16%) among HCPs surveyed in this study. A 
319 lack of staff, lack of a suitable setting and resources, concerns regarding appropriate 
320 financial reimbursement, and lack of confidence with vaccine discussion, have all been 
321 identified as potential barriers to this approach by HCPs in previous studies  30–33. Potential 
322 solutions include employing dedicated vaccination staff (including vaccination specialist 
323 midwives) and improving vaccine education (as discussed above). Further pragmatic and/or 
324 qualitative research is also required to establish the feasibility and effectiveness of this 
325 approach, and to establish facilitators and barriers to its acceptance among both pregnant 
326 women and HCPs.
327
328 Strengths and limitations
329 This study had significant numbers of respondents, and by distributing our questionnaire at 
330 four hospitals in southern England we attempted to maximize the demographic diversity of 
331 our study population. That said, the responses to the questionnaire cannot be taken as 
332 representative of all pregnant women and maternity HCPs. Reported actual/intended 
333 vaccine uptake was higher among our questionnaire respondents than national reports of 
334 vaccine uptake, and this may limit the generalisability of our study findings. All of our 
335 respondents were recruited from antenatal clinics at tertiary hospitals, and therefore it is 
336 possible that our sample was missing subsets of the population that tend to be more anti-
337 vaccination. Future studies would therefore benefit from including a greater number of study 
338 sites over a wider geographic area, and recruiting from different types of sites (including 
339 smaller non-tertiary hospitals and primary care) and perhaps utilizing online recruitment via 
340 popular websites and social media.
341
342 Another limitation is that we relied upon self-reported vaccination status/intention, and there 
343 is therefore potential reporting bias in our estimations, which may have been improved by 
344 verification of women’s medical records following delivery; however recent evidence does 
345 suggest that self-reported intention correlates well with actual uptake of vaccination  34  35. 
346 Finally, the number of pregnant women/HCPs approached, and the number who declined 
9347 participation (as well as their reasons for doing so) was not recorded, and we are therefore 
348 unable to report this.
349
350 Conclusions
351 Whilst the high acceptance of vaccination among respondents in this study was 
352 encouraging, misconceptions still exist regarding vaccine safety and efficacy. Further 
353 education of multidisciplinary HCPs is essential, and active vaccine promotion needs to be 
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564 Table 3: Ordinal regression analysis of factors predicting healthcare professionals’ confidence in 









573 Figure 1: Reasons why the surveyed pregnant women did not intend to receive influenza or 


















































623 Figure 2: Healthcare professionals’ confidence providing advice to pregnant women 



















643 Figure 3: Healthcare professionals’ opinions regarding the optimal healthcare site at which 






650 1. Questions for pregnant women analyzed in this study
651
652 (1) Have you received either of the following vaccines in this pregnancy? 
653 Flu (influenza) ☐ Yes  ☐ No
654 Whooping cough (pertussis) ☐ Yes  ☐ No
655
656 (1a) If no, why have you not yet received these vaccines?
657
658 For flu (influenza)?     For whooping cough(pertussis)?
659
660 I don’t intend to receive the vaccine ☐ ☐
661 I haven’t been offered the vaccine yet ☐ ☐
662 I haven’t got round to getting the vaccine yet☐ ☐




667 (1b) If you don’t intend to receive these vaccines in this pregnancy, please specify the reasons why. Tick 
668 as many apply:
669
670 For flu (influenza)?     For pertussis (whooping cough)?
671
672 I worry that the injection might be painful ☐ ☐
673 My midwife did not advise it ☐ ☐
674 My obstetrician did not advise it ☐ ☐
675 My GP did not advise it ☐ ☐
676 My family/friends advised against it ☐ ☐
677 I don’t believe the vaccine is effective ☐ ☐
678 I worry about potential side effects for my baby ☐ ☐
679 I worry about potential side effects for me ☐ ☐
680 Vaccination was not offered to me ☐ ☐
681 There is not enough safety data ☐ ☐
682 I don’t have enough information to decide ☐ ☐
683 I am concerned about information in the media ☐ ☐
684 I don’t want to attend extra hospital/GP visits ☐ ☐
685 Religious or other convictions ☐ ☐
686 Other (please specify): 
687 ………………………………………………………………………………………………………………………………
688 ………..
689 (2) How old are you in years?
690 16-24 ☐ 25-30 ☐31-35 ☐36-40 ☐41-45 ☐  46+ ☐ 
691  
692
693 (3) How many weeks pregnant are you?
694 Less than 12 ☐ 12-16 ☐17-20 ☐21-30 ☐31-36 ☐37+ ☐ 
695
696
697 (4) To what ethnic group do you feel you belong? (Please circle)
698
699 White Black / African / Caribbean / Black British
700 - English / Welsh / Scottish / Northern Irish - African 
701 / British Irish - Caribbean 
702 - Gypsy or Irish Traveller - Other (please specify)……………………………..
703 - Other (please specify) ……………………………..
20
704
705 Mixed/Multiple ethnic groups Other ethnic group
706 - White and Black Caribbean - Arab 
707 - White and Black African - Other (please specify)…………………………
708 - White and Asian 
709 - Other (please specify) ……………………………..
710
711 Asian / Asian British I’d prefer not to say
712 - Indian 
713 - Pakistani 
714 - Bangladeshi 
715 - Chinese 
716 - Other (please specify) …………………………
717
718
719 (5) Have you had any children before?
720 ☐ Yes.
721 If yes, how many?....................................................................
722 What are their ages?
723 Child 1: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐
724 Child 2: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐














739 2. Questions for maternity healthcare professionals analyzed in this study
740
741
742 (1) How confident would you feel about providing advice regarding the flu (influenza) vaccine to women during 
743 pregnancy?
744 ☐ Not at all confident
745 ☐ Slightly confident
746 ☐ Somewhat confident
747 ☐ Moderately confident
748 ☐ Extremely confident
749
750
751 (2) How confident would you feel about providing advice regarding the whooping cough (pertussis) vaccine to 
752 women during pregnancy?
753 ☐ Not at all confident
754 ☐ Slightly confident
755 ☐ Somewhat confident
756 ☐ Moderately confident
757 ☐ Extremely confident
758
759 (3) In your opinion, where should these vaccines be delivered to pregnant women?  
760
761 ☐ Primary care (GP practice)
762 ☐ Midwifery services (Community services)
21
763 ☐ Secondary care at time of antenatal scans or appointments
764 ☐ Other (please specify)…………………………………………………………………………………………………..
765
766 (4) Which healthcare professional group do you belong to?      
767 ☐ Obstetrics
768 ☐ Midwifery
769 ☐ Other (please state) …………………………………………………………………………………………
770
771
772 (5) How long have you worked in maternity care?
773 ☐ Under 2 years
774 ☐ 2-5 years
775 ☐ 6-10 years 
776 ☐ 11-15 years
777 ☐ 16-20 years 
778 ☐ 21+ years 
779
780 (6) What is your grade?
781 1. Midwifery/nursing staff
782 Band 4 ☐       Band 5 ☐       Band 6 ☐         Band 7 ☐        Band 8 ☐        Band 9 ☐
783 2. Obstetricians
784 ST 1-3 (or equivalent) ☐     ST 4-6 (or equivalent) ☐      ST 7-8 (or equivalent) ☐     Consultant ☐
785
786 (7) Have you had any children before?
787 ☐ Yes.
788 If yes, how many?....................................................................
789 What are their ages?
790 Child 1: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐
791 Child 2: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐
792 Child 3: Less than 1 ☐   1-5 ☐    6-10 ☐    11-16 ☐    17+ ☐ 




797 (8) To what ethnic group do you feel you belong? (Please circle)
798
799 White Black / African / Caribbean / Black British
800 - English / Welsh / Scottish / Northern Irish - African 
801 / British Irish - Caribbean 
802 - Gypsy or Irish Traveller - Other (please specify)……………………………..
803 - Other (please specify) ……………………………..
804
805 Mixed/Multiple ethnic groups Other ethnic group
806 - White and Black Caribbean - Arab 
807 - White and Black African - Other (please specify)…………………………
808 - White and Asian 
809 - Other (please specify) ……………………………..
810
811 Asian / Asian British I’d prefer not to say
812 - Indian 
813 - Pakistani 
814 - Bangladeshi 
815 - Chinese 
816 - Other (please specify) …………………………
817
818











829 3. Free text comments (all received from pregnant women)
830
831 “Many vaccines contain unsafe levels of mercury, in some cases are produced on human 
832 tissue (DNA) and contain various other toxins. I believe a baby is born with a perfect 
833 immune system which takes up to three years to fully develop and it’s not healthy injecting 
834 a perfectly healthy child with chemicals and toxins (mercury)” 
835
836 “We were not offered the whooping cough [vaccine] until much later on in the pregnancy – 
837 close to it being too late. No flu jab offered – we would have done so otherwise.”
838
839 “I would like the opportunity to ask more questions and have more information before 
840 agreeing to vaccination”
841
